SEC Form 4 · accession 0000904454-15-000166
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jessica Baker Flechtner
Officer — Sr. VP of Research
Period of report
Mar 2, 2015
Accepted (ET)
Mar 4, 2015 · 6:37 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 2, 2015 | M | 1,470 | $2.38 | A | 3,351 | D | |
| Common Stock | Mar 2, 2015 | S | 1,470 | $8.50 | D | 1,881 | D | |
| Common Stock | Mar 2, 2015 | M | 2,284 | $2.86 | A | 4,165 | D | |
| Common Stock | Mar 2, 2015 | S | 2,284 | $8.50 | D | 1,881 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.38 | Mar 2, 2015 | M | 1,470 | D | — | Jun 29, 2019 | Common Stock | 1,470 | 0 | D |
| Stock Option (Right to Buy)F3 | $2.86 | Mar 2, 2015 | M | 2,284 | D | — | Mar 27, 2020 | Common Stock | 2,284 | 2,283 | D |
Explanation of responses
- F1The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- F2The option was granted on 6/30/2009 and vested 100% on 12/9/2009.
- F3The option was granted on 3/28/2010 and will vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.